Caribou Biosciences, Inc.: shareholders and insiders

CRBUNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$0.28

November 20, 2026Market cap $31M

What Ploutos Investor adds for Caribou Biosciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from 2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 31% since Nov 5, 2026, when the 10-Q these figures come from was filed ($0.41 then, $0.28 on Nov 20, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to –, from their own Form 4 filings.

Bought on the market

–

nobody

Sold on the market

$47.5K

4 people

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan62%
  • The rest38%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $47.5K by 4 people

  • 2025: no buys, no sales
  • 2026: no buys, sold $47.5K by 4 people
  • Feb 25, 2026Timothy P KellyChief Technology Officer
    Kind
  • Feb 24, 2026Barbara G McclungChief Legal Officer
    Kind10b5-1
  • Feb 24, 2026Timothy P KellyChief Technology Officer
    Kind
  • Feb 24, 2026Ruhi Ahmad KhanChief Business Officer
    Kind10b5-1
  • Feb 24, 2026Tina M. AlbertsonChief Medical Officer
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before – the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by CRBU's officers and directors from 2021 up to November 21, 2025, 5 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%1 On a 13DJul 27, 2026 Latest filing
  • BlackRock, Inc.
    Share of class7.20%
  • The City Canyon Family Trust dated May 31, 2021with 2 more persons
    Share of class5.00%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • The City Canyon Family Trust dated May 31, 20215.0%From the filing of Apr 25, 2025

    The Reporting Persons intend to continuously review their investment in the Issuer, and may in the future determine to (1) acquire additional securities of the Issuer, through open market purchases, private agreements, or otherwise (subject to the Issuer's Insider Trading Policy); (2) dispose of all or a portion of the securities of the Issuer owned by them (including through 10b5-1 plans) (subject to the Issuer's Insider Trading Policy); or (3) take any other available course of action. Notwithstanding anything contained herein, the Reporting Persons specifically reserve the right to change their intention with respect to any or all of such matters. Dr. Haurwitz is the President and Chief…

    From the filing of Apr 25, 2025
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • The Vanguard Group4.86%Apr 30, 202513G/A
  • Bank of America2.20%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+166%
  • Millennium Mgmt (Englander)
    In the quarter
  • Renaissance Technologies
    In the quarter-7.8%
  • AQR Capital
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 11.6% of its shares outstanding were held short, -2.8% since the report before.

Shares held short
12.55M
11.6%
Since the report before12.91M on Sep 30, 2026
-2.8%
1.5
8.14M
More days to cover thanof 4,578 US-listed companies with enough volume
21%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 9.78M
  • Nov 15, 2023: Shares held short 8.95M
  • Nov 30, 2023: Shares held short 9.89M
  • Dec 15, 2023: Shares held short 9.94M
  • Dec 29, 2023: Shares held short 9.64M
  • Jan 12, 2024: Shares held short 9.86M
  • Jan 31, 2024: Shares held short 10.12M
  • Feb 15, 2024: Shares held short 9.69M
  • Feb 29, 2024: Shares held short 9.39M
  • Mar 15, 2024: Shares held short 10.07M
  • Mar 28, 2024: Shares held short 10.20M
  • Apr 15, 2024: Shares held short 11.34M
  • Apr 30, 2024: Shares held short 10.64M
  • May 15, 2024: Shares held short 10.49M
  • May 31, 2024: Shares held short 11.51M
  • Jun 14, 2024: Shares held short 12.27M
  • Jun 28, 2024: Shares held short 10.25M
  • Jul 15, 2024: Shares held short 11.64M
  • Jul 31, 2024: Shares held short 12.43M
  • Aug 15, 2024: Shares held short 11.52M
  • Aug 30, 2024: Shares held short 11.38M
  • Sep 13, 2024: Shares held short 11.63M
  • Sep 30, 2024: Shares held short 11.67M
  • Oct 15, 2024: Shares held short 11.51M
  • Oct 31, 2024: Shares held short 9.94M
  • Nov 15, 2024: Shares held short 7.42M
  • Nov 29, 2024: Shares held short 8.62M
  • Dec 13, 2024: Shares held short 9.80M
  • Dec 31, 2024: Shares held short 9.54M
  • Jan 15, 2025: Shares held short 10.80M
  • Jan 31, 2025: Shares held short 8.86M
  • Feb 14, 2025: Shares held short 8.91M
  • Feb 28, 2025: Shares held short 10.22M
  • Mar 14, 2025: Shares held short 8.82M
  • Mar 31, 2025: Shares held short 9.89M
  • Apr 15, 2025: Shares held short 9.48M
  • Apr 30, 2025: Shares held short 7.63M
  • May 15, 2025: Shares held short 9.49M
  • May 30, 2025: Shares held short 8.34M
  • Jun 13, 2025: Shares held short 10.95M
  • Jun 30, 2025: Shares held short 6.19M
  • Jul 15, 2025: Shares held short 4.62M
  • Jul 31, 2025: Shares held short 3.90M
  • Aug 15, 2025: Shares held short 3.89M
  • Aug 29, 2025: Shares held short 4.03M
  • Sep 15, 2025: Shares held short 4.11M
  • Sep 30, 2025: Shares held short 4.07M
  • Oct 15, 2025: Shares held short 3.67M
  • Oct 31, 2025: Shares held short 3.55M
  • Nov 14, 2025: Shares held short 5.62M
  • Nov 28, 2025: Shares held short 6.14M
  • Dec 15, 2025: Shares held short 6.24M
  • Dec 31, 2025: Shares held short 6.50M
  • Jan 15, 2026: Shares held short 6.79M
  • Jan 30, 2026: Shares held short 7.53M
  • Feb 13, 2026: Shares held short 7.77M
  • Feb 27, 2026: Shares held short 7.23M
  • Mar 13, 2026: Shares held short 7.06M
  • Mar 31, 2026: Shares held short 6.47M
  • Apr 15, 2026: Shares held short 6.77M
  • Apr 30, 2026: Shares held short 7.12M
  • May 15, 2026: Shares held short 7.14M
  • May 29, 2026: Shares held short 7.45M
  • Jun 15, 2026: Shares held short 7.53M
  • Jun 30, 2026: Shares held short 9.63M
  • Jul 15, 2026: Shares held short 11.59M
  • Jul 31, 2026: Shares held short 11.64M
  • Aug 14, 2026: Shares held short 12.47M
  • Aug 31, 2026: Shares held short 12.50M
  • Sep 15, 2026: Shares held short 12.98M
  • Sep 30, 2026: Shares held short 12.91M
  • Oct 15, 2026: Shares held short 12.55M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading55.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 55.5% of the shares in the reported trades were short sales, against 58.2% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
55.5%
The 14 beforeOct 14, 2026 – Nov 2, 2026
58.2%
Change
-2.7 pts
Short sales a dayon average, of 1.18M shares
653.7K
More than atof 3,666 US-listed companies, same days
69%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 71%
  • Oct 15, 2026: Short sales 63.4%
  • Oct 16, 2026: Short sales 59.6%
  • Oct 19, 2026: Short sales 58.2%
  • Oct 20, 2026: Short sales 53%
  • Oct 21, 2026: Short sales 65%
  • Oct 22, 2026: Short sales 52.1%
  • Oct 23, 2026: Short sales 61.9%
  • Oct 26, 2026: Short sales 60.1%
  • Oct 27, 2026: Short sales 34.1%
  • Oct 28, 2026: Short sales 49%
  • Oct 29, 2026: Short sales 60.6%
  • Oct 30, 2026: Short sales 62.3%
  • Nov 2, 2026: Short sales 52.7%
  • Nov 3, 2026: Short sales 58.6%
  • Nov 4, 2026: Short sales 78.8%
  • Nov 5, 2026: Short sales 71.4%
  • Nov 6, 2026: Short sales 65.9%
  • Nov 9, 2026: Short sales 39.5%
  • Nov 10, 2026: Short sales 56.7%
  • Nov 11, 2026: Short sales 55%
  • Nov 12, 2026: Short sales 63.9%
  • Nov 13, 2026: Short sales 57.5%
  • Nov 16, 2026: Short sales 61.2%
  • Nov 17, 2026: Short sales 59%
  • Nov 18, 2026: Short sales 59.2%
  • Nov 19, 2026: Short sales 41.6%
  • Nov 20, 2026: Short sales 45.7%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

4.55M Insiders' shares4.70% Of the company
  • Rachel E. HaurwitzPresident and CEO
    Directly–
  • Barbara G McclungChief Legal Officer
    Directly481.6K
  • Steven KannerChief Scientific Officer
    Directly431.6K
  • Ruhi Ahmad KhanChief Business Officer
    Directly105.0K
  • Timothy P KellyChief Technology Officer
    Directly73.1K
  • Tina M. AlbertsonChief Medical Officer
    Directly68.5K
  • Sriram RyaliChief Financial Officer
    Directly17.4K

A lower bound: it counts only the 7 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

11 ETFs holding it0.04% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.04%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.01%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.00%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.00%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • SCHBSchwab U.S. Broad Market ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

11 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

137 Managers, Q2 2026$85M Value of their positions
  • Q3 2025: Managers 117
  • Q4 2025: Managers 124
  • Q1 2026: Managers 138
  • Q2 2026: Managers 137

Institutional investors by quarter

The fund managers holding CRBU, quarter by quarter, from Q3 2021 to Q2 2025, 16 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 137 managers held 48.75M shares, worth $85M. During the quarter 22 opened a position, 24 closed one, 46 added and 23 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+265%
  • Pfizer
    In the quarter
  • Vanguard Capital Management
    In the quarter+12%
  • Mackenzie Financial
    In the quarter+287%
  • Renaissance Technologies
    In the quarter+7.1%
  • Kynam Capital Management
    In the quarter
  • Geode Capital Management
    In the quarter+133%
  • Acadian Asset Management
    In the quarter+92%
  • State Street
    In the quarter+286%
  • Bank of America
    In the quarter+8.8%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Caribou Biosciences's filings show?

Who buys and sells is one part of Caribou Biosciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CRBU's shareholders

Didn't find what you were looking for?

Ask us
Have CRBU's insiders bought or sold?

From – to – Caribou Biosciences's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold CRBU?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $3.2M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.